• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSB2500038 甲型肝炎灭活疫苗(人二倍体细胞) Hepatitis A Vaccine,Inactivated Injection Biological Products(2.2) Supplementary Application 2025-03-20 Zhejiang Pukang BIOTECHNOLOGY Co Ltd view
CXSB2101010 甲型肝炎灭活疫苗(人二倍体细胞) Hepatitis A Vaccine,Inactivated Injection Biological Products(原15) Supplementary Application 2021-05-12 Liaoning Chengda Biotechnology Co Ltd view
J0401024 甲型肝炎灭活疫苗 Hepatitis A Vaccine,Inactivated Injection Biological Products Supplementary Application 2004-11-18 Cobner Co Ltd Shanghai Representative Office Certificate Issued 2005-03-10 view
CYSB2400034 甲型肝炎灭活疫苗(人二倍体细胞) Hepatitis A Vaccine(Human Diploid Cell),Inactivated Injection Biological Products Supplementary Application 2024-02-06 Aimei Action Biopharmaceutical Co Ltd view
CXSB2101011 甲型肝炎灭活疫苗(人二倍体细胞) Hepatitis A Vaccine,Inactivated Injection Biological Products(原15) Supplementary Application 2021-05-12 Liaoning Chengda Biotechnology Co Ltd view
JYSB2200012 甲型肝炎灭活疫苗(人二倍体细胞) Hepatitis A Vaccine(Human Diploid Cell),Inactivated Injection Biological Products Supplementary Application 2022-01-19 Merck Sharp & Dohme Corp view
CYSB2400032 甲型肝炎灭活疫苗(人二倍体细胞) Hepatitis A Vaccine(Human Diploid Cell),Inactivated Injection Biological Products Supplementary Application 2024-02-06 Aimei Action Biopharmaceutical Co Ltd view
JYSB2200196 甲型肝炎灭活疫苗(人二倍体细胞) Hepatitis A Vaccine(Human Diploid Cell),Inactivated Injection Biological Products Supplementary Application 2022-10-12 Merck Sharp & Dohme Corp view
CXSL2400725 甲型肝炎灭活疫苗(人二倍体细胞) Hepatitis A Vaccine,Inactivated Injection Biological Products(2.2) New Drug Application 2024-10-24 Zhejiang Pukang BIOTECHNOLOGY Co Ltd view
CYSB2400035 甲型肝炎灭活疫苗(人二倍体细胞) Hepatitis A Vaccine(Human Diploid Cell),Inactivated Injection Biological Products Supplementary Application 2024-02-06 Aimei Action Biopharmaceutical Co Ltd view
JYSB2200010 甲型肝炎灭活疫苗(人二倍体细胞) Hepatitis A Vaccine(Human Diploid Cell),Inactivated Injection Biological Products Supplementary Application 2022-01-19 Merck Sharp & Dohme Corp;Taiwan Biotech Co Ltd view
JYSB2200197 甲型肝炎灭活疫苗(人二倍体细胞) Hepatitis A Vaccine(Human Diploid Cell),Inactivated Injection Biological Products Supplementary Application 2022-10-12 Merck Sharp & Dohme Corp view
CXSL2400726 甲型肝炎灭活疫苗(人二倍体细胞) Hepatitis A Vaccine,Inactivated Injection Biological Products(2.2) New Drug Application 2024-10-24 Zhejiang Pukang BIOTECHNOLOGY Co Ltd view
JYSB2200009 甲型肝炎灭活疫苗(人二倍体细胞) Hepatitis A Vaccine(Human Diploid Cell),Inactivated Injection Biological Products Supplementary Application 2022-01-19 Merck Sharp & Dohme Corp view
CXSB2500039 甲型肝炎灭活疫苗(人二倍体细胞) Hepatitis A Vaccine,Inactivated Injection Biological Products(2.2) Supplementary Application 2025-03-20 Zhejiang Pukang BIOTECHNOLOGY Co Ltd view
JYSB2200011 甲型肝炎灭活疫苗(人二倍体细胞) Hepatitis A Vaccine(Human Diploid Cell),Inactivated Injection Biological Products Supplementary Application 2022-01-19 Merck Sharp & Dohme Corp view
CYSB2400033 甲型肝炎灭活疫苗(人二倍体细胞) Hepatitis A Vaccine(Human Diploid Cell),Inactivated Injection Biological Products Supplementary Application 2024-02-06 Aimei Action Biopharmaceutical Co Ltd view
JYSB1100277 甲型肝炎灭活疫苗 Hepatitis A Vaccine,Inactivated Injection Biological Products Supplementary Application 2012-01-12 GlaxoSmithKline Biologicals s.a. GlaxoSmithKline Biologicals SA Certificate Issued 2012-06-08 view
JYSB0800018 甲型肝炎灭活疫苗 Hepatitis A Vaccine,Inactivated Injection Biological Products Supplementary Application 2008-02-22 GlaxoSmithKline Biologicals s.a. GlaxoSmithKline Biologicals SA Certificate Issued 2009-04-09 view
JYSB0900166 甲型肝炎灭活疫苗 Hepatitis A Vaccine,Inactivated Injection Biological Products Supplementary Application 2009-08-14 GlaxoSmithKline Biologicals s.a. GlaxoSmithKline Biologicals SA Certificate Issued 2010-04-02 view